Navigating the NASH Maze

The availability of 2 approved medicines for the treatment of idiopathic pulmonary fibrosis (IPF) has stimulated an explosion in fibrosis research and in the search for new anti-fibrotic agents. Nowhere is this more evident than in the field of non-alcoholic steatohepatitis (NASH). While there have been multiple review articles covering NASH of late, TherapeutAix is […]

TherapeutAix present at The Society for Medicines Research meeting

Test Tube with multicoloured liquid

The Society for Medicines Research (SMR) is holding a meeting on 26th September 2018 in Stevenage titled, ‘The Best of Both Worlds: Innovation, Collaboration and Synergy between CROs and their Client Partners.’ The meeting will showcase innovation in science that has emerged from successful Client-CRO partnerships which have moved beyond fee-for-service agreements, towards much broader […]

We’d like to send you our company updates, invites to events and any other relevant news. By providing your details and subscribing to this list, you are giving us your consent to send you these updates.

We’ll always be mindful of how often we send our updates and you can amend your preferences at any time.

We’ll never sell or swap your data with any organisation and we’ll store your details securely, respecting your trust and privacy. Please view our privacy policy for further details.

Marketing Permissions
Please select all the ways you would like to hear from TherapeutAix:
You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.